+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oncogene"

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021 - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Cell Division Protein FtsZ - Pipeline Review, H2 2020 - Product Thumbnail Image

Cell Division Protein FtsZ - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 36 Pages
  • Global
From
Apoptosis Regulator BAX - Pipeline Review, H2 2020 - Product Thumbnail Image

Apoptosis Regulator BAX - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 45 Pages
  • Global
From
Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H2 2020 - Product Thumbnail Image

Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 147 Pages
  • Global
From
Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 46 Pages
  • Global
From
Proto Oncogene Tyrosine Protein Kinase Receptor Ret Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Proto Oncogene Tyrosine Protein Kinase Receptor Ret Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 80 Pages
  • Global
From
Proto Oncogene Mas Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Proto Oncogene Mas Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 38 Pages
  • Global
From
Serine/Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) - Drugs in Development, 2021 - Product Thumbnail Image

Serine/Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) - Drugs in Development, 2021

  • Report
  • April 2021
  • 85 Pages
  • Global
From
Macrophage Colony Stimulating Factor 1 Receptor - Pipeline Review, H1 2020 - Product Thumbnail Image

Macrophage Colony Stimulating Factor 1 Receptor - Pipeline Review, H1 2020

  • Drug Pipelines
  • March 2020
  • 255 Pages
  • Global
From
Proto Oncogene Tyrosine Protein Kinase Src - Pipeline Review, H2 2020 - Product Thumbnail Image

Proto Oncogene Tyrosine Protein Kinase Src - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 99 Pages
  • Global
From
RAF Proto Oncogene Serine/Threonine Protein Kinase - Pipeline Review, H1 2020 - Product Thumbnail Image

RAF Proto Oncogene Serine/Threonine Protein Kinase - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 91 Pages
  • Global
From
Proto Oncogene Tyrosine Protein Kinase ROS - Pipeline Review, H1 2020 - Product Thumbnail Image

Proto Oncogene Tyrosine Protein Kinase ROS - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 90 Pages
  • Global
From
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • Drug Pipelines
  • November 2018
  • 39 Pages
  • Global
From
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • Drug Pipelines
  • November 2018
  • 35 Pages
  • Global
From
Tyrosine Protein Kinase Fyn - Pipeline Review, H1 2020 - Product Thumbnail Image

Tyrosine Protein Kinase Fyn - Pipeline Review, H1 2020

  • Drug Pipelines
  • January 2020
  • 103 Pages
  • Global
From
Serine Threonine Protein Kinase Pim 1 - Pipeline Review, H2 2019 - Product Thumbnail Image

Serine Threonine Protein Kinase Pim 1 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 50 Pages
  • Global
From
Serine Threonine Protein Kinase Pim 3 - Pipeline Review, H2 2019 - Product Thumbnail Image

Serine Threonine Protein Kinase Pim 3 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 41 Pages
  • Global
From
Tyrosine Protein Kinase Receptor UFO - Pipeline Review, H2 2019 - Product Thumbnail Image

Tyrosine Protein Kinase Receptor UFO - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 185 Pages
  • Global
From
Serine Threonine Protein Kinase Pim 2 - Pipeline Review, H2 2019 - Product Thumbnail Image

Serine Threonine Protein Kinase Pim 2 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 45 Pages
  • Global
From
Receptor Tyrosine Protein Kinase ERBB 4 - Pipeline Review, H2 2019 - Product Thumbnail Image

Receptor Tyrosine Protein Kinase ERBB 4 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 151 Pages
  • Global
From
Loading Indicator

The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies. The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more